The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 17948981 |
10 |
Highly Potent, Water Soluble Benzimidazole Antagonist for Activated alpha(4)beta(1) Integrin. |
University of California Davis |
| 17915848 |
48 |
Small molecule inhibitors of integrin alpha2beta1. |
University of Pennsylvania |
| 16377201 |
24 |
Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists. |
Daiichi Pharmaceutical |
| 17194595 |
18 |
Synthesis and biological evaluation of benzoic acid derivatives as potent, orally active VLA-4 antagonists. |
Daiichi Pharmaceutical |
| 16495061 |
8 |
Selection of a 2-azabicyclo[2.2.2]octane-based alpha4beta1 integrin antagonist as an inhaled anti-asthmatic agent. |
Johnson & Johnson Pharmaceutical |
| 17035017 |
25 |
2,6-Quinolinyl derivatives as potent VLA-4 antagonists. |
Ucb Pharma |
| 16455247 |
15 |
Pyridone derivatives as potent and selective VLA-4 integrin antagonists. |
Glaxosmithkline |
| 16931004 |
29 |
Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists. |
Glaxosmithkline |
| 17041919 |
51 |
Structure-activity relationship studies of a series of peptidomimetic ligands for alpha(4) beta(1) integrin on Jurkat T-leukemia cells. |
University of California Davis |
| 16112583 |
74 |
Aza-bicyclic amino acid carboxamides as alpha4beta1/alpha4beta7 integrin receptor antagonists. |
Johnson & Johnson Pharmaceutical |
| 16722660 |
60 |
Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists. |
Johnson & Johnson Pharmaceutical |
Search and Browse
